Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB), a commercial-stage biopharmaceutical company with a "GOOD" InvestingPro Financial Health rating, has positioned itself as an innovative player in the ...

Monoclonal antibody (mAb) therapy involves making large amounts of antibodies that recognize antigens that are usually found on the surface of cancer cells. They are then injected into the body ...

The SADA technology was developed at Memorial Sloan Kettering Cancer Center and is exclusively licensed to Y-mAbs. Presentation of significant preclinical and translational pharmacokinetics data ...

Shares in US biotech Y-mAbs Therapeutics have lost almost a third of their value after FDA advisors unanimously rejected its brain cancer therapy 131I-omburtamab in 16 to 0 vote.

Hong Kong-listed Shanghai Henlius Biotech Inc, a subsidiary of Fosun Pharma, announced on Wednesday that its anti-PD-1 mAb, ...

(the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic ...

(the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic ...

Country Bowls club teamed up with the Golfers from La Torre Golf Society to have a Bowls Pro-Am event in aid of our nominated ...